Allogeneic peripheral blood stem cell transplantation with anti-thymocyte globulin versus allogeneic bone marrow transplantation without anti-thymocyte globulin

We compared severe graft-versus-host-disease (GvHD) free and relapse-free survival and other transplantation outcomes of acute myeloid leukemia (AML) patients given bone marrow (BM) without anti-thymocyte globulin (ATG) versus peripheral blood stem cells (PBSC) with ATG after myeloablative condition...

Descripción completa

Detalles Bibliográficos
Autores principales: Baron, Frédéric, Galimard, Jacques-Emmanue, Labopin, Myriam, Yakoub-Agha, Ibrahim, Niittyvuopio, Riitta, Kröger, Nicolaus, Griskevicius, Laimonas, Wu, Depei, Forcade, Edouard, Richard, Carlos, Aljurf, Mahmoud, Helbig, Grzegorz, Labussière-Wallet, Hélène, Mohty, Mohamad, Nagler, Arnon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ferrata Storti Foundation 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7109757/
https://www.ncbi.nlm.nih.gov/pubmed/31413093
http://dx.doi.org/10.3324/haematol.2019.227603

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7109757/
https://www.ncbi.nlm.nih.gov/pubmed/31413093
http://dx.doi.org/10.3324/haematol.2019.227603

Ejemplares similares